Topotecan and paclitaxel in previously treated patients with relapsed small cell lung cancer: Phase II trial of the North Central Cancer Treatment Group

Grace K. Dy, James R. Jett, Francois J. Geoffroy, Keith D. Krewer, Henry Tazelaar, Matthew Maurer, Kendrith Rowland, James Mailliard, James Krook, Shaker Dakhil, Leila Kutteh, John Kugler, Donald Wender

Research output: Contribution to journalArticle

5 Scopus citations
Original languageEnglish (US)
Pages (from-to)211-217
Number of pages7
JournalJournal of Thoracic Oncology
Volume1
Issue number3
DOIs
StatePublished - Mar 2006

ASJC Scopus subject areas

  • Oncology
  • Pulmonary and Respiratory Medicine

Cite this

Dy, G. K., Jett, J. R., Geoffroy, F. J., Krewer, K. D., Tazelaar, H., Maurer, M., Rowland, K., Mailliard, J., Krook, J., Dakhil, S., Kutteh, L., Kugler, J., & Wender, D. (2006). Topotecan and paclitaxel in previously treated patients with relapsed small cell lung cancer: Phase II trial of the North Central Cancer Treatment Group. Journal of Thoracic Oncology, 1(3), 211-217. https://doi.org/10.1016/S1556-0864(15)31570-7